Alzheimer's screening just got easier, more accurate with ne

A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest pathology.

Related Keywords

Canada , Montreal , Quebec , Lily Ramsey , Mcgill University , University Of Lund , University Of Gothenburg , Lund University , Blood , Blood Test , Aging , Lzheimer 39s Disease , Amyloidosis , Biomarker , Rain , Pathology , Protein , Research , Tau Protein ,